Ophthalmic community perception of new medication needs

by William C. Stewart, Jeanette A. Stewart, Lindsay A. Nelson
Published 2018-05-01

Glaucoma clinical trial design: A review of the literature

by William C. Stewart, Jeanette A. Stewart, Lindsay A. Nelson
Published 2014-01-01

A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension

by David A Godfrey, Lee S Peplinski, Jeanette A Stewart, William C Stewart
Published 2009-01-01

Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients

by Michael J Miyashiro, Samuel C Lo, Jeanette A Stewart, et al
Published 2010-11-01

Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapy

by J Charles Henry, James H Peace, Jeanette A Stewart, William C Stewart
Published 2008-10-01

Single-versus double-masking in glaucoma clinical trials

by D L DeMill, Barbara M Wirostko, Lindsay A Nelson, Jeanette A Stewart, William C Stewart
Published 2016-01-01

Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany

by Jeanette A. Stewart, Lindsay A. Nelson, Michael S. Kristoffersen, Sonja Schölzel, Dietmar Schnober, Ulrich Thelen, William C. Stewart
Published 2013-04-01